Trade Summary

Yesterday, Adams Jennifer McKie, serving as Dir at Eton Pharmaceuticals, Inc. (ETON), sold 50,000 shares at $32.48 per share, for a total transaction value of $1,623,795.00.

This sale represents a 100.00% decrease in Adams Jennifer McKie's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 17, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 17, 2026 at 5:08 PM ET, meaning the disclosure happened on the same day as the trade.

Eton Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.